Evidence map›Paper›PMID 40056203›Full record

ReviewNaunyn-Schmiedeberg's archives of pharmacology2025

The adipokines in oral cancer pathogenesis and its potential as a new therapeutic approach.

Xue Wang, Jiapeng Wang, Xuemei Zhao, Jiayin Zhang, Yan Zhang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xue WangDepartment of Stomatology, Jilin Province FAW General Hospital, Jilin, 130000, China.
Jiapeng WangDepartment of Orthopedics, Jilin Province FAW General Hospital, Jilin, 130000, China. 13147708686@163.com.ORCID 0009-0000-5737-7165
Xuemei ZhaoDepartment of Stomatology, Jilin Province FAW General Hospital, Jilin, 130000, China.
Jiayin ZhangDepartment of Stomatology, Jilin Province FAW General Hospital, Jilin, 130000, China.
Yan ZhangMedical Department, Changchun Sci-Tech University, Changchun, 130000, China.

Funding

Jilin Province Science and Technology Development Plan Project No. YDZJ202401090ZYTS
6 · The paper itself

Abstract

The involvement of adipose tissue in the development of cancer is currently the subject of an increasing number of research due to the growing relevance of lipid metabolism in tumor growth. Obesity influences the tumor immune microenvironment (TME) in oral cancer. Visceral white adipose tissue (WAT) consists of adipocytes, connective tissue, immune cells, and stromovascular cells. The metabolic processes of immune cells within the adipose tissue of individuals with obesity predominantly depend on oxidative phosphorylation (intrinsically) and are characterized by elevated levels of M2 macrophages, Treg cells, Th2 cells, and eosinophils from an extrinsic perspective. The adipokines secreted by adipocytes facilitate communication with adjacent tissues to regulate glucose and lipid metabolism. Obesity influences cancer progression through the dysregulation of adipocytokines, characterized by an augmented synthesis of the oncogenic adipokine leptin, coupled with a reduced secretion of adiponectin. Under standard physiological settings, these adipokines fulfill essential roles in sustaining homeostasis. This review analyzed the influence of adipocytes on oral cancer by detailing the mediators released by adipocytes. Comprehending the molecular foundations of the protumor roles of adipokines in oral cancers might provide novel treatment targets.

Indexed as

AdipokinesMouth NeoplasmsAdipocytesAnimalsHumansObesityTumor MicroenvironmentAdipokinesAdipocyteAdipokineAdipose tissueLeptinOral cancer

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.